大唐药业
(836433)
| 流通市值：8.19亿 | | | 总市值：12.52亿 |
| 流通股本：1.69亿 | | | 总股本：2.59亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 37,068,157.66 | 120,815,757.96 | 99,143,226.1 | 129,374,770.72 |
| 应收票据及应收账款 | 49,053,843.38 | 50,729,931.13 | 52,451,604.55 | 53,727,221.81 |
| 其中：应收票据 | 44,700 | 100,000 | 273,764.7 | 397,819.7 |
| 应收账款 | 49,009,143.38 | 50,629,931.13 | 52,177,839.85 | 53,329,402.11 |
| 应收款项融资 | 909,917.72 | - | - | 150,000 |
| 预付款项 | 14,870,384.28 | 12,805,623.18 | 12,456,610.34 | 17,499,560.78 |
| 其他应收款合计 | 267,408.13 | 320,644.24 | 379,076.38 | 331,051.13 |
| 存货 | 70,133,500.87 | 63,738,502.55 | 63,381,769.46 | 50,693,666.56 |
| 其他流动资产 | 941,926.6 | 1,235,455.33 | 5,103,764.71 | 169,019.17 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 198,770,709.24 | 264,771,495.21 | 273,446,861.72 | 304,996,484.41 |
| 非流动资产: | | | | |
| 长期应收款 | 506,526.37 | 506,526.37 | 506,526.37 | - |
| 固定资产 | 123,533,524.66 | 126,224,101.81 | 116,689,751.95 | 84,669,714.55 |
| 在建工程 | 269,655,928.58 | 263,377,154.83 | 204,907,191.86 | 191,246,834.24 |
| 使用权资产 | 2,056,276.06 | 2,102,663.43 | 2,022,969.76 | 312,783.64 |
| 无形资产 | 21,302,246.34 | 21,455,631.93 | 21,609,017.52 | 21,763,534.93 |
| 长期待摊费用 | 1,302,744.14 | 1,482,460.55 | 1,506,531.65 | 1,674,769.97 |
| 递延所得税资产 | 4,941,064.31 | 5,044,934.52 | 5,181,369.01 | 3,606,224.89 |
| 其他非流动资产 | 56,601,284.56 | 55,292,602.23 | 66,354,146.62 | 82,976,452.56 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 479,899,595.02 | 475,486,075.67 | 418,777,504.74 | 386,250,314.78 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 678,670,304.26 | 740,257,570.88 | 692,224,366.46 | 691,246,799.19 |
| 流动负债: | | | | |
| 短期借款 | 98,084,458.32 | 123,825,526.2 | 121,786,501.73 | 124,515,193.33 |
| 应付票据及应付账款 | 41,280,399.24 | 74,996,172.08 | 26,185,715.1 | 13,727,752.75 |
| 其中：应付票据 | - | - | - | 150,000 |
| 应付账款 | 41,280,399.24 | 74,996,172.08 | 26,185,715.1 | 13,577,752.75 |
| 合同负债 | 16,439,730.18 | 19,836,304.57 | 17,922,968.47 | 13,793,286.09 |
| 应付职工薪酬 | 4,271,371.05 | 4,465,269.9 | 3,766,524.44 | 3,956,510.78 |
| 应交税费 | 172,143.29 | 210,800.29 | 175,222.83 | 4,258,620.13 |
| 其他应付款合计 | 12,985,837.59 | 13,001,389.61 | 13,260,495.51 | 13,248,034.55 |
| 一年内到期的非流动负债 | 362,175.95 | 474,282.15 | - | - |
| 其他流动负债 | 818,032.74 | 1,092,264.93 | 1,314,052.84 | 1,185,851.28 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 174,414,148.36 | 237,902,009.73 | 184,411,480.92 | 174,685,248.91 |
| 非流动负债: | | | | |
| 租赁负债 | 1,189,385.31 | 1,189,385.31 | 1,766,554.66 | 374,668.84 |
| 长期应付款 | 407,249.94 | 407,249.94 | 407,249.94 | 407,249.94 |
| 递延收益 | 12,740,157.47 | 12,085,702 | 10,803,717.82 | 10,457,984.01 |
| 递延所得税负债 | 347,702.15 | 334,236.63 | 34,192.88 | 47,154.27 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 14,684,494.87 | 14,016,573.88 | 13,011,715.3 | 11,287,057.06 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 189,098,643.23 | 251,918,583.61 | 197,423,196.22 | 185,972,305.97 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 258,777,181 | 258,777,181 | 258,790,681 | 258,790,681 |
| 资本公积 | 130,755,572.08 | 130,755,572.08 | 134,125,640.83 | 133,833,609.58 |
| 减:库存股 | 4,651,375 | 4,651,375 | 4,673,350 | 4,673,350 |
| 盈余公积 | 32,198,080.59 | 32,198,080.59 | 30,986,190.38 | 30,986,190.38 |
| 未分配利润 | 72,492,202.36 | 71,259,528.6 | 75,572,008.03 | 86,337,362.26 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 489,571,661.03 | 488,338,987.27 | 494,801,170.24 | 505,274,493.22 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 489,571,661.03 | 488,338,987.27 | 494,801,170.24 | 505,274,493.22 |
| 负债和股东权益合计 | 678,670,304.26 | 740,257,570.88 | 692,224,366.46 | 691,246,799.19 |
| 公告日期 | 2024-04-22 | 2024-03-20 | 2023-10-27 | 2023-08-17 |
| 审计意见(境内) | | 标准无保留意见 | | |